Document is current
Any future updates will be listed below
-
Authors
Naumann, Nicole
Dangelo, Vito
Lübke, Johannes
Bresser, Jakob
Hagen, Volker
Dengler, Jolanta
Metzgeroth, Georgia
Kreil, Sebastian
Hockenberger, Tabea
Hofmann, Wolf-Karsten
Fabarius, Alice
Saussele, Susanne
Cross, Nicholas C. P.
Reiter, Andreas
Schwaab, Juliana
-
Funding
Funding for this research was provided by:
Medizinische Fakultät Mannheim der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 8 July 2025
First Online: 18 July 2025
Declarations
:
: J.S. received honoraria from Novartis, GSK, Astra Zeneca and Blueprint Medicines and research funding from Blueprint Medicines and Cogent, A.R. received consulting fees, honoraria and research funding from Abbvie, AOP Orphan Pharmaceuticals, Blueprint Medicines, BMS, GlaxoSmithKline, Incyte and Novartis and was member on an entity’s Board of Directors or advisory committees of Abbvie, AOP Orphan Pharmaceuticals, Blueprint Medicines, BMS, GSK, Incyte and Novartis. S.S. received consultancy honoraria and research support from Novartis, Incyte and Roche. N.C.P.C. received consultancy honoraria and research support from Novartis. V.H. received consulting fees and/or honoraria from Novartis, Roche, Pfizer, BMS, Boehringer Ingelheim, Amgen, Celgene, AstraZeneca, Lilly, mteacademy. Other authors have no competing interest.
